Dr. Jallouk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2220 Pierce Ave., PRB 777
Nashville, TN 37232
Education & Training
Washington University in St. Louis School of MedicineClass of 2014
Certifications & Licensure
TN State Medical License 2023 - 2025
TX State Medical License 2021 - 2024
MO State Medical License 2017 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 27 citationsDelivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles.Andrew P. Jallouk, Rohun U. Palekar, Jon N. Marsh, Hua Pan, Christine T.N. Pham
Bioconjugate Chemistry. 2015-07-02 - 65 citationsCytolytic nanoparticles attenuate HIV-1 infectivity.Joshua L. Hood, Andrew P. Jallouk, Nancy Campbell, Lee Ratner, Samuel A. Wickline
Antiviral Therapy. 2012-01-01 - 10 citationsAxicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response.Andrew P Jallouk, Sushanth Gouni, Jason Westin, Lei Feng, Haleigh Mistry
Haematologica. 2023-04-01
Press Mentions
Innovative New Cell Therapies Could Finally Get at Tough-to-Target CancersNovember 2nd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
